Enanta Pharmaceuticals | ENTA - Ebitda





Ebitda Alterar Data
AbbVie USD 5.37B 1.85B 2025-12
Amgen USD 5.14B 775M 2025-12
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Immunic USD -22.78M 753K 2024-06
Incyte USD 367.97M 46.53M 2026-03
Insmed USD -148.3M 165.88M 2026-03
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
J&J USD 7.19B 2.32B 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 66.78M 83.54M 2025-12
Merck USD 6.3B 2.09B 2025-12
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 5.3B 530M 2026-03
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 5.99B 5.23B 2026-03
PTC Therapeutics USD -70.99M 91.62M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03